Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Synthetic Biologics Inc.
DescriptionHuman mAb against Bordetella pertussis
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationPertussis
Indication DetailsTreat pertussis
Regulatory Designation U.S. - Orphan Drug (Treat pertussis)
PartnerIntrexon Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today